Home › Kanser sa Pantog
Pag-aaral pangklinika para sa Kanser sa Pantog na nagre-recruit sa U.S.
140 pag-aaral para sa Kanser sa Pantog ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY36 pag-aaral
- Nashville, TN31 pag-aaral
- Houston, TX31 pag-aaral
- Dallas, TX27 pag-aaral
- Boston, MA26 pag-aaral
- Washington, DC26 pag-aaral
- Los Angeles, CA25 pag-aaral
- Baltimore, MD24 pag-aaral
- Philadelphia, PA23 pag-aaral
- Edison, NJ23 pag-aaral
- St. Louis, MO22 pag-aaral
- Chicago, IL21 pag-aaral
- Seattle, WA21 pag-aaral
- Durham, NC20 pag-aaral
- Columbus, OH19 pag-aaral
- Cleveland, OH18 pag-aaral
- Queens, NY17 pag-aaral
- Atlanta, GA16 pag-aaral
- Baldwin Park, CA14 pag-aaral
- San Antonio, TX13 pag-aaral
- San Francisco, CA13 pag-aaral
- Portland, OR13 pag-aaral
- Grand Rapids, MI12 pag-aaral
- Orange, CA12 pag-aaral
- Birmingham, AL12 pag-aaral
- Staten Island, NY12 pag-aaral
- New Rochelle, NY12 pag-aaral
- Salt Lake City, UT11 pag-aaral
- Denver, CO11 pag-aaral
- San Diego, CA11 pag-aaral
- Little Rock, AR11 pag-aaral
- Irvine, CA11 pag-aaral
- Austin, TX11 pag-aaral
- Rochester, MN11 pag-aaral
- Oklahoma City, OK11 pag-aaral
- East Norwalk, CT11 pag-aaral
- Milwaukee, WI11 pag-aaral
- Greenburgh, NY11 pag-aaral
- Sacramento, CA10 pag-aaral
- Detroit, MI10 pag-aaral
Ayos sa estado
- Alabama12 pag-aaral
- Alaska4 pag-aaral
- Arizona19 pag-aaral
- Arkansas16 pag-aaral
- California53 pag-aaral
- Colorado20 pag-aaral
- Connecticut10 pag-aaral
- Delaware4 pag-aaral
- District of Columbia17 pag-aaral
- Florida36 pag-aaral
- Georgia19 pag-aaral
- Idaho6 pag-aaral
- Illinois30 pag-aaral
- Indiana13 pag-aaral
- Iowa13 pag-aaral
- Kansas15 pag-aaral
- Kentucky5 pag-aaral
- Louisiana13 pag-aaral
- Maryland36 pag-aaral
- Massachusetts31 pag-aaral
- Michigan24 pag-aaral
- Minnesota23 pag-aaral
- Mississippi3 pag-aaral
- Missouri26 pag-aaral
- Montana7 pag-aaral
- Nebraska11 pag-aaral
- Nevada6 pag-aaral
- New Hampshire3 pag-aaral
- New Jersey27 pag-aaral
- New Mexico3 pag-aaral
- New York42 pag-aaral
- North Carolina26 pag-aaral
- North Dakota4 pag-aaral
- Ohio35 pag-aaral
- Oklahoma12 pag-aaral
- Oregon14 pag-aaral
- Pennsylvania29 pag-aaral
- Rhode Island4 pag-aaral
- South Carolina16 pag-aaral
- South Dakota4 pag-aaral
- Tennessee34 pag-aaral
- Texas49 pag-aaral
- Utah15 pag-aaral
- Vermont3 pag-aaral
- Virginia24 pag-aaral
- Washington25 pag-aaral
- West Virginia6 pag-aaral
- Wisconsin17 pag-aaral
- Wyoming4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07222488Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03866382Evaluation for NCI Surgery Branch Clinical Research Protocols
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00001823Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07225205BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based Therapy
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07869836A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07419295Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06770582Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT00026884The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06995898A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07090499A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07206225A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06465069cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05366881Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Nob 4, 2026 · NCT05792722Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06760819FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05614739Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07660055Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07061964Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06525571Risk-Enabled Therapy After Initiating EV/Pembro for Bladder Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07908979Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06963346Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07144319En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT0423576418F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06503146Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.